AI in Precision Medicine Market, By Component (Hardware, Software, and Services), By Therapeutic Application, By Technology, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5426
|
Published Date
June 2026
|
Pages
420
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
AI in Precision Medicine Market size was valued at USD 1,056.3 Million in 2025, expanding to a CAGR of 29.7% from 2026 to 2033.
In precision medicine, artificial intelligence (AI) refers to the application of advanced data analytics and machine learning systems to process and interpret large and complex patient datasets. These datasets may include genomic information, clinical records, diagnostic reports, imaging data, and lifestyle-related factors. By analyzing these diverse inputs, AI enables healthcare providers to uncover hidden patterns and relationships that are often difficult to detect through conventional methods. The integration of AI in precision medicine supports more personalized and targeted healthcare approaches by improving disease prevention strategies, enhancing diagnostic accuracy, and optimizing treatment selection. It also strengthens the ability to predict patient outcomes, identify potential health risks at earlier stages, and support timely clinical interventions. As a result, AI is playing an increasingly important role in enabling data-driven decision-making and advancing individualized patient care.
AI in Precision Medicine Market- Market Dynamics
Rising Integration of Multi-Omics Data, Advanced Analytics, and Personalized Therapies Driving Market Growth
The growth of the AI in precision medicine market is being driven by the rapid expansion of healthcare data and the growing need to convert this vast information into meaningful clinical insights. Healthcare systems, including hospitals, research institutes, and diagnostic laboratories, generate large and complex datasets from genomic sequencing, proteomic studies, electronic health records, medical imaging technologies, and wearable health devices. Artificial intelligence plays a critical role in processing, organizing, and interpreting these multi-dimensional datasets, enabling healthcare professionals to make more accurate, data-driven, and individualized treatment decisions. According to the World Health Organization (WHO), global digital health adoption has accelerated significantly in recent years, with over 60% of member states now implementing national digital health strategies to strengthen healthcare data systems and improve decision-making capabilities. Recent advancements include AI-powered genomic analysis tools, large-scale healthcare foundation models, and predictive algorithms capable of identifying disease risks and potential treatment responses with higher precision. According to industry estimates, global healthcare data is expanding at a rate of over 30% annually, significantly increasing the need for advanced analytics and intelligent decision-support systems. In parallel, healthcare organizations are adopting integrated data ecosystems that combine clinical, molecular, and real-world patient data into unified platforms. This integration is enhancing early disease detection, improving predictive accuracy, and enabling more proactive and personalized care delivery.
Another key driver of market growth is the increasing emphasis on personalized treatment strategies and the rising need to improve efficiency across the drug development lifecycle. Pharmaceutical and biotechnology companies are increasingly deploying AI to identify novel therapeutic targets, optimize patient selection for clinical trials, and more accurately predict treatment outcomes. These capabilities help streamline research processes, reduce development timelines, and improve the success rate of new therapies. Emerging applications such as AI-based biomarker discovery, advanced patient stratification models, and precision matching platforms are further strengthening the ecosystem. Additionally, the growing adoption of precision oncology, rising focus on rare genetic disorders, and increasing demand for tailored chronic disease management solutions are collectively accelerating market expansion.
AI in Precision Medicine Market- Segmentation Analysis:
The Global AI in Precision Medicine Market is segmented on the basis of Component, Therapeutic Application, Technology, End-Use, and Region.
Based on component, the AI in precision medicine market is segmented into hardware, software, and services. Among these, the software segment holds a leading position due to the rising adoption of AI-driven platforms for genomic interpretation, predictive healthcare analytics, clinical decision support systems, and advanced patient stratification. These solutions enable healthcare providers to process complex medical data efficiently and generate actionable insights that support more accurate diagnosis and personalized treatment planning. The hardware segment, on the other hand, includes high-performance computing systems, cloud-based and on-premise data storage infrastructure, and specialized AI processing units that are essential for managing and analyzing large-scale healthcare datasets. According to the World Health Organization (WHO), more than 60% of countries globally have now implemented digital health strategies, reflecting the rapid expansion of digital infrastructure and supporting technologies required for AI-powered healthcare solutions. This widespread digital transformation is further strengthening demand across both software and hardware segments in precision medicine.
Based on therapeutic application, the AI in precision medicine market is categorized into oncology, neurology, cardiology, infectious diseases, rare diseases, and other medical fields. Among these, oncology represents the dominant segment owing to the extensive use of AI technologies in early cancer detection, tumor classification, biomarker identification, treatment response prediction, and personalized therapy design. AI-powered tools enable clinicians to analyze large volumes of genomic, proteomic, and clinical data, facilitating more precise and targeted cancer treatment approaches. The growing global burden of cancer is a key factor supporting this segment’s expansion. According to the World Health Organization (WHO), cancer remains one of the leading causes of death worldwide, accounting for nearly 10 million deaths annually. This rising disease burden, combined with increasing investments in precision oncology research and AI-based diagnostic innovations, continues to accelerate the adoption of advanced precision medicine solutions in oncology, making it the leading therapeutic application segment.
AI in Precision Medicine Market- Geographical Insights
North America holds a leading position in the AI in precision medicine market, supported by its highly advanced healthcare infrastructure, strong biotechnology and pharmaceutical ecosystem, and early adoption of digital health technologies. The region benefits from large-scale genomic research programs, widespread implementation of electronic health records, and substantial investments in artificial intelligence across clinical and research applications. Healthcare providers, life sciences companies, and academic institutions are increasingly integrating AI-driven solutions into drug discovery, biomarker identification, clinical decision support, and personalized treatment planning. According to the U.S. government’s healthcare digitization progress reports, electronic health record adoption among hospitals in the United States exceeds 90%, reflecting a highly digitized healthcare environment that supports the rapid deployment of AI-based precision medicine tools.
Europe is also emerging as a key market for AI in precision medicine, driven by increasing investments in healthcare digitalization, genomic medicine initiatives, and AI-enabled clinical research programs. Governments and healthcare organizations across the region are actively promoting personalized healthcare approaches and data-driven disease management strategies. The growing adoption of AI tools for clinical decision support, population health analytics, and precision oncology is further contributing to market expansion. A notable initiative supporting this growth is the 1+ Million Genomes Initiative, which facilitates secure access to genomic and health-related data across participating European countries. According to the European Commission, the initiative aims to improve cross-border data sharing and accelerate genomic research to strengthen healthcare innovation. This collaborative framework is enhancing disease understanding, supporting large-scale research collaboration, and accelerating the development of AI-powered precision medicine solutions across Europe.
United States AI in Precision Medicine Market- Key Insights
The United States accounts for the largest share of the AI in precision medicine market, driven by its highly developed healthcare system, strong biotechnology and pharmaceutical industry base, advanced digital infrastructure, and significant investments in artificial intelligence research. The country hosts a wide network of pharmaceutical companies, biotechnology firms, AI-driven startups, and leading academic medical centers that are actively engaged in developing and deploying precision medicine solutions. The increasing adoption of genomic sequencing technologies, electronic health records, and AI-enabled clinical decision support systems is further accelerating market growth. In addition, rising investments in AI-based drug discovery, biomarker identification, and predictive analytics are enabling faster, more accurate, and highly personalized treatment development. The availability of large-scale healthcare datasets, strong government and private research funding, and robust collaboration between technology and life sciences companies continue to reinforce the United States’ dominant position in the global precision medicine landscape.
AI in Precision Medicine Market – Competitive Landscape:
The AI in precision medicine market is moderately competitive, with a growing number of technology providers, healthcare organizations, and life sciences companies focusing on integrating artificial intelligence with genomics, clinical data analytics, molecular diagnostics, and drug discovery platforms. The competitive environment is increasingly shaped by the development of end-to-end precision medicine ecosystems that combine patient data management, biomarker discovery, predictive analytics, and treatment optimization within unified platforms to support personalized healthcare delivery. In addition, companies are investing heavily in advanced machine learning models, healthcare-focused foundation AI systems, and multimodal analytics platforms capable of processing genomic, imaging, and clinical datasets simultaneously. Strategic mergers, acquisitions, and technology partnerships are further enabling market participants to strengthen their capabilities, expand product portfolios, and enhance global market presence.
Recent Developments
- In February 2025, Tempus AI completed the acquisition of Ambry Genetics, significantly expanding its precision medicine and molecular diagnostics portfolio. This acquisition strengthened Tempus AI’s genomic database and enhanced its capabilities in genetic testing and AI-driven disease detection.
- In 2025, Illumina Inc. entered into a strategic collaboration with Tempus AI to integrate advanced genomic sequencing technologies with AI-powered analytics. The partnership aims to improve molecular profiling, enhance interpretation of complex genomic datasets, and accelerate the adoption of precision medicine globally.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL AI IN PRECISION MEDICINE MARKET KEY PLAYERS
- Tempus AI
- Illumina
- NVIDIA
- IBM
- Microsoft
- SOPHiA GENETICS
- IQVIA
- Guardant Health
- Astrazeneca
- Sanofi
- Roche
- Thermo Fisher Scientific
- Qiagen
- Bio-Rad Laboratories
- Others
GLOBAL AI IN PRECISION MEDICINE MARKET, BY COMPONENT- MARKET ANALYSIS, 2020-2033
- Hardware
- Software
- Services
GLOBAL AI IN PRECISION MEDICINE MARKET, BY THERAPEUTIC APPLICATION- MARKET ANALYSIS, 2020-2033
- Oncology
- Neurology
- Cardiology
- Infectious diseases
- Rare diseases
- Others
GLOBAL AI IN PRECISION MEDICINE MARKET, BY TECNOLOGY- MARKET ANALYSIS, 2020-2033
- Machine Learning (ML)
- Natural Language Processing (NLP)
- Computer Vision
- Others
GLOBAL AI IN PRECISION MEDICINE MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. AI in Precision Medicine Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. AI in Precision Medicine Market Snippet by Component
2.1.2. AI in Precision Medicine Market Snippet by Therapeutic Application
2.1.3. AI in Precision Medicine Market Snippet by Technology
2.1.4. AI in Precision Medicine Market Snippet by End-Use
2.1.5. AI in Precision Medicine Market Snippet by Country
2.1.6. AI in Precision Medicine Market Snippet by Region
2.2. Competitive Insights
3. AI in Precision Medicine Key Market Trends
3.1. AI in Precision Medicine Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. AI in Precision Medicine Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. AI in Precision Medicine Market Opportunities
3.4. AI in Precision Medicine Market Future Trends
4. AI in Precision Medicine Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. AI in Precision Medicine Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. AI in Precision Medicine Market Landscape
6.1. AI in Precision Medicine Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. AI in Precision Medicine Market – By Component
7.1. Overview
7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
7.1.2. Hardware
7.1.3. Software
7.1.4. Services
8. AI in Precision Medicine Market – By Therapeutic Application
8.1. Overview
8.1.1. Segment Share Analysis, By Therapeutic Application, 2025 & 2033 (%)
8.1.2. Oncology
8.1.3. Neurology
8.1.4. Cardiology
8.1.5. Infectious diseases
8.1.6. Rare diseases
8.1.7. Others
9. AI in Precision Medicine Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
9.1.2. Machine Learning (ML)
9.1.3. Natural Language Processing (NLP)
9.1.4. Computer Vision
9.1.5. Others
10. AI in Precision Medicine Market – By End-Use
10.1. Overview
10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
10.1.2. Drug Discovery & Development
10.1.3. Genomic Analysis
10.1.4. Precision Diagnostics
10.1.5. Clinical Decision Support
10.1.6. Predictive Analytics
10.1.7. Others
11. AI in Precision Medicine Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. AI in Precision Medicine Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. AI in Precision Medicine Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. AI in Precision Medicine Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. AI in Precision Medicine Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. AI in Precision Medicine Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- AI in Precision Medicine Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Tempus AI
12.2.2. Illumina
12.2.3. NVIDIA
12.2.4. IBM
12.2.5. Microsoft
12.2.6. Google
12.2.7. SOPHiA GENETICS
12.2.8. IQVIA
12.2.9. Guardant Health
12.2.10. Astrazeneca
12.2.11. Sanofi
12.2.12. Roche
12.2.13. Thermo Fisher Scientific
12.2.14. Qiagen
12.2.15. Bio-Rad Laboratories
12.2.16. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL AI IN PRECISION MEDICINE MARKET KEY PLAYERS
- Tempus AI
- Illumina
- NVIDIA
- IBM
- Microsoft
- SOPHiA GENETICS
- IQVIA
- Guardant Health
- Astrazeneca
- Sanofi
- Roche
- Thermo Fisher Scientific
- Qiagen
- Bio-Rad Laboratories
- Others
GLOBAL AI IN PRECISION MEDICINE MARKET, BY COMPONENT- MARKET ANALYSIS, 2020-2033
- Hardware
- Software
- Services
GLOBAL AI IN PRECISION MEDICINE MARKET, BY THERAPEUTIC APPLICATION- MARKET ANALYSIS, 2020-2033
- Oncology
- Neurology
- Cardiology
- Infectious diseases
- Rare diseases
- Others
GLOBAL AI IN PRECISION MEDICINE MARKET, BY TECNOLOGY- MARKET ANALYSIS, 2020-2033
- Machine Learning (ML)
- Natural Language Processing (NLP)
- Computer Vision
- Others
GLOBAL AI IN PRECISION MEDICINE MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
